Second Edition Pharmaceutical Cannabis Report 2021: Featuring Almirall, Bayer and Novartis Among Others – ResearchAndMarkets.com
Cannabis Law Report
DECEMBER 23, 2021
In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals. billion by 2025. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading.
Let's personalize your content